COLLEGIUM PHARMACEUTICAL INC. - COMMON STOCK

Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024

08 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire

Collegium Provides 2024 Financial Guidance

03 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire

Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent

27 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire

Collegium Announces $25 Million Accelerated Share Repurchase Program

09 ноя 2023 07:00:01 Источник Nasdaq GlobeNewswire

Collegium to Participate in Upcoming Investor Conferences

08 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire

Collegium Reports Third Quarter 2023 Financial Results

07 ноя 2023 15:01:01 Источник Nasdaq GlobeNewswire

Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023

24 окт 2023 07:00:01 Источник Nasdaq GlobeNewswire

Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023

28 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026

24 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

Collegium Announces $50 Million Accelerated Share Repurchase Program

07 авг 2023 06:30:00 Источник Nasdaq GlobeNewswire

Collegium Reports Record 1H’23 Net Revenue of $280.3 Million, Up 35% Year-over-Year

03 авг 2023 15:01:00 Источник Nasdaq GlobeNewswire

Collegium to Report Second Quarter 2023 Financial Results on August 3, 2023

20 июл 2023 07:00:00 Источник Nasdaq GlobeNewswire

Collegium to Participate in Jefferies Healthcare Conference

01 июн 2023 07:00:01 Источник Nasdaq GlobeNewswire

Collegium Reports First Quarter 2023 Financial Results

04 май 2023 15:01:00 Источник Nasdaq GlobeNewswire

Collegium to Report First Quarter 2023 Financial Results on May 4, 2023

20 апр 2023 07:00:01 Источник Nasdaq GlobeNewswire

Collegium to Participate in 22nd Annual Needham Virtual Healthcare Conference

11 апр 2023 07:00:02 Источник Nasdaq GlobeNewswire

Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results

23 фев 2023 15:01:00 Источник Nasdaq GlobeNewswire

Collegium Publishes Inaugural 2022 Environmental, Social and Governance Report

22 фев 2023 07:00:01 Источник Nasdaq GlobeNewswire

Collegium Pharmaceutical, Inc. Prices Upsized $210.0 Million Convertible Senior Notes Offering

07 фев 2023 20:54:36 Источник Nasdaq GlobeNewswire

Collegium Pharmaceutical, Inc. Announces Proposed Convertible Senior Notes Offering

06 фев 2023 15:08:00 Источник Nasdaq GlobeNewswire